Patent ID: 6423695
Filing Date: 2002-07-23
Classification: A61K

Abstract:
A method of selectively modulating Th1 and Th2 responses in a peripheral blood mononuclear cell of a patient infected with a virus comprising: identifying a patient in need of treatment for a viral infection; administering a compound according to formula 1 to the patient wherein R2, R3, R7 and R8 are independently selected from H, OH, CN, N3, halogens,CH2OH, NH2, OCH3, NHCH3, ONHCH3, SCH3, SPh, alkenyl, lower alkyl, lower alkyl amines or substituted heterocycles; and administering the compound to the peripheral blood mononuclear cell at a concentration effective to selectively modulate the Th1 and Th2 responses relative to each other.